The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Clostridium difficile: its disease and toxins
Open accessAbstract
Clostridium difficile is the etiologic agent of pseudomembranous colitis, a severe, sometimes fatal disease that occurs in adults undergoing antimicrobial therapy. The disease, ironically, has been most effectively treated with antibiotics, although some of the newer methods of treatment such as the replacement of the bowel flora may prove more beneficial for patients who continue to relapse with pseudomembranous colitis. The organism produces two potent exotoxins designated toxin A and toxin B. Toxin A is an enterotoxin believed to be responsible for the diarrhea and mucosal tissue damage which occur during the disease. Toxin B is an extremely potent cytotoxin, but its role in the disease has not been as well studied. There appears to be a cascade of events which result in the expression of the activity of these toxins, and these events, ranging from the recognition of a trisaccharide receptor by toxin A to the synergistic action of the toxins and their possible dissemination in the body, are discussed in this review. The advantages and disadvantages of the various assays, including tissue culture assay, enzyme immunoassay, and latex agglutination, currently used in the clinical diagnosis of the disease also are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
HALL, I. C. (1935) · American Journal of Diseases of Children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 772
CLOSTRIDIUM DIFFICILE AND THE ÆTIOLOGY OF PSEUDOMEMBRANOUS COLITIS
Larson, H. E., Price, A. B., Honour, P., & Borriello, S. P. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90912-1 · Cited by 652
Selective and differential medium for isolation of Clostridium difficile
George, W. L., Sutter, V. L., Citron, D., & Finegold, S. M. (1979) · Journal of Clinical Microbiology · doi:10.1128/jcm.9.2.214-219.1979 · Cited by 632
Clindamycin-Associated Colitis: A Prospective Study
TEDESCO, F. J., BARTON, R. W., & ALPERS, D. H. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-429 · Cited by 606
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis
Bartlett, J. G., Moon, N., Chang, T. W., Taylor, N., & Onderdonk, A. B. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90457-2 · Cited by 517
Kim, K. H., Fekety, R., Batts, D. H., Brown, D., Cudmore, M., Silva, J., & Waters, D. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.1.42 · Cited by 499
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L., & Kasper, D. L. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.5.701 · Cited by 472
Identification of Clostridium difficile as a cause of pseudomembranous colitis.
George, R. H., Symonds, J. M., Dimock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M. R., Alexander-Williams, J., & Burdon, D. W. (1978) · BMJ · doi:10.1136/bmj.1.6114.695 · Cited by 451
Cited by
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Clostridium difficile Toxins: Mechanism of Action and Role in Disease
Voth, D. E., & Ballard, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.247-263.2005 · Cited by 1,104
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 657
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649
“difficile strains producing exotoxins are pathogenic.(1,7,8) The rising mortality of CDAD since 2000 has been associated with emergence of the BI/NAP-1/027 strain that is characterized by markedly increased production of toxins A and B, resistance to fluoroquinolones, and production of binary toxin.”
BackgroundClostridium Difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/648363 · Cited by 631
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Stubbs, S. L. J., Brazier, J. S., O’Neill, G. L., & Duerden, B. I. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.2.461-463.1999 · Cited by 547
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion
Sears, C. L., & Kaper, J. B. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.1.167-215.1996 · Cited by 508
The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins
Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C., Mann, M., & Aktories, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13932 · Cited by 478
Carey-Ann, B. D., & Carroll, K. C. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-13 · Cited by 423
Castagliuolo, I., Riegler, M. F., Valenick, L., LaMont, J. T., & Pothoulakis, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.302-307.1999 · Cited by 408
Clostridium difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30141083 · Cited by 398
McFarland, L. V., Surawicz, C. M., & Stamm, W. E. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.3.678 · Cited by 378
Identification of Toxin A-Negative, Toxin B-Positive Clostridium difficile by PCR
Kato, H., Kato, N., Watanabe, K., Iwai, N., Nakamura, H., Yamamoto, T., Suzuki, K., Kim, S.-M., Chong, Y., & Wasito, E. B. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.8.2178-2182.1998 · Cited by 357
Diagnosis and Treatment of Clostridium difficile Colitis
Fekety, R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500010081036 · Cited by 354
Lemee, L., Dhalluin, A., Testelin, S., Mattrat, M.-A., Maillard, K., Lemeland, J.-F., & Pons, J.-L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5710-5714.2004 · Cited by 337
Definition of the single integration site of the pathogenicity locus in Clostridium difficile
Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M., & von Eichel-Streiber, C. (1996) · Gene · doi:10.1016/s0378-1119(96)00398-8 · Cited by 330
Leggett, M. J., McDonnell, G., Denyer, S. P., Setlow, P., & Maillard, J.-Y. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05336.x · Cited by 312
Persson, S., Torpdahl and, M., & Olsen, K. E. P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02092.x · Cited by 305
Clostridium difficile Infection Associated with Antineoplastic Chemotherapy: A Review
Anand, A., & Glatt, A. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.1.109 · Cited by 295
Pothoulakis, C., Kelly, C. P., Joshi, M. A., Gao, N., O'Keane, C. J., Castagliuolo, I., & Lamont, J. T. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90280-p · Cited by 281
Frizzled proteins are colonic epithelial receptors for C. difficile toxin B
Tao, L., Zhang, J., Meraner, P., Tovaglieri, A., Wu, X., Gerhard, R., Zhang, X., Stallcup, W. B., Miao, J., He, X., et al. (2016) · Nature · doi:10.1038/nature19799 · Cited by 279
Leung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Spigaglia, P., & Mastrantonio, P. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3470-3475.2002 · Cited by 277
Molecular characterization of the Clostridium difficile toxin A gene
Dove, C. H., Wang, S. Z., Price, S. B., Phelps, C. J., Lyerly, D. M., Wilkins, T. D., & Johnson, J. L. (1990) · Infection and Immunity · doi:10.1128/iai.58.2.480-488.1990 · Cited by 269
Self-citationIntravenous immunoglobulin therapy for severe Clostridium difficile colitis
Salcedo, J., Keates, S., Pothoulakis, C., Warny, M., Castagliuolo, I., LaMont, J. T., & Kelly, C. P. (1997) · Gut · doi:10.1136/gut.41.3.366 · Cited by 264
GroEL (Hsp60) of Clostridium difficile is involved in cell adherence.
Hennequin, C., Collignon, A., Bourlioux, P., Waligora-Dupriet, A.-J., Karjalainen, T., Barc, M.-C., & Porcheray, F. (2001) · Microbiology · doi:10.1099/00221287-147-1-87 · Cited by 226
“Virulence is mainly due to the production of two protein exotoxins : toxins A and B, although other toxic factors have been described (Lyerly et al., 1988).”
BackgroundMartinez, R. D., & Wilkins, T. D. (1988) · Infection and Immunity · doi:10.1128/iai.56.5.1215-1221.1988 · Cited by 59
Self-citationReliable protein production in a Pseudomonas fluorescens expression system
Retallack, D. M., Jin, H., & Chew, L. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2011.09.010 · Cited by 46
Metadata
- Authors
- Lyerly, D. M., Krivan, H. C., & Wilkins, T. D.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1988-01
- Volume
- 1
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2167811982
- Cited by
- 576
- References
- 151
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.